4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-022695
EVP, Cell & Genetic Therapies gave up 1,466 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Sanna Bastiano · EVP, Cell & Genetic Therapies
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-31 | Shares withheld for taxes : show line 1 in the form | −1,466 | $313.74 | $459,943 | 47,802 | D |
Loading xslF345X04/doc4.xml…